Showing results (871-880 of 888) with videos related to
Sort By:
Pageof 89
EMBO Molecular Medicine|February 16, 2026
Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signalingAdeline Cezard, Déborah Brea-Diakite, Virginie Vasseur, et al.The European Respiratory Journal|April 23, 2021
Recommendations for respiratory syncytial virus surveillance at the national levelAnne C Teirlinck, Eeva K Broberg, Are Stuwitz Berg, et al.Influenza and Other Respiratory Viruses|July 13, 2021
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countriesLisa Staadegaard, Saverio Caini, Sonam Wangchuk, et al.Open Forum Infectious Diseases|June 29, 2023
Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance NetworkMelissa K Andrew, Henrique Pott, Lisa Staadegaard, et al.BMJ Paediatrics Open|February 3, 2026
EPIC-ND: a multi-site, randomised controlled trial evaluating the effectiveness of social prescribing for the unmet social needs of children with a neurodisability and their parent/carers - a study protocolKatarina Ostojic, Serena Chiu, Sandra Takchi, et al.Nature Immunology|February 3, 2021
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicityHéloïse Flament, Matthieu Rouland, Lucie Beaudoin, et al.Cardiovascular Research|February 8, 2022
Rapid neutrophil mobilization by VCAM-1+ endothelial cell-derived extracellular vesiclesNaveed Akbar, Adam T Braithwaite, Emma M Corr, et al.American Journal of Human Genetics|January 17, 2017
Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent NephronophthisisMaxence S Macia, Jan Halbritter, Marion Delous, et al.Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|June 9, 2016
High throughput toxicity screening and intracellular detection of nanomaterialsAndrew R Collins, Balasubramanyam Annangi, Laura Rubio, et al.JCI Insight|December 22, 2025
Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasisDavid Strawn, James G Krueger, Robert Bissonnette, et al.Pageof 89